PaxMedica to discuss significance of Phase 3 study resultsInterview to be webcast on Tuesday, August 15, 2023, at 10:30 am…
MVID is a life-threatening and ultra-rare autosomal recessive disease that affects newborns and children, leading to intestinal failure, significant morbidity…
~ Approval of Study Represents Progression Toward Full Phase 3 Evaluation of PF614 ~~ Study to Assess PF614 Time of…
AFTER ACQUIRING ESN GROUP, XCELERATE SIGNS MARKETING AGREEMENTProductSector to Provide Brand Development AssistanceMAULDIN, SC / ACCESSWIRE / August 8, 2023…
LAS VEGAS, NV / ACCESSWIRE / August 8, 2023 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), (the ''Company'' or ''CLS''), a…
Funding Accelerates the Development of Compliance Automation SolutionsLOS ANGELES, CA / ACCESSWIRE / August 8, 2023 / LighthouseAI™, an industry…
Second Quarter Revenue Increased 18% to $147 MillionFORT MYERS, FL / ACCESSWIRE / August 8, 2023 / NeoGenomics, Inc. (NASDAQ:NEO)…
ANN ARBOR, MI / ACCESSWIRE / August 8, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health…
Net sales for the second quarter of 2023 were $16.1 million, down 7.2%, compared to $17.4 million for the second…
Post-Hoc Analysis of SOLOIST-WHF Clinical Data Published in Journal of the American College of Cardiology: Heart Failure Risk Reductions of…